Secondary loss of effectiveness among rheumatoid arthritis patients treated with tumour necrosis factor inhibitors

被引：0
|
作者：
Aaltonen, K. [1 ]
Isomaki, P. [2 ,3 ]
Joensuu, J. [1 ]
Sokka, T. [4 ,5 ]
Peltomaa, R. [6 ]
Piril, L. [7 ]
Varjolahti-Lehtinen, T. [8 ]
Uutela, T. [9 ]
Malmi, T. [10 ]
Ekman, P. [11 ]
Kononoff, A. [12 ]
Eklund, K. [6 ,13 ]
机构：
[1] Univ Helsinki, Fac Pharm, Helsinki, Finland
[2] Tampere Univ Hosp, Dept Med, Tampere, Finland
[3] Univ Tampere, Fac Med, Tampere, Finland
[4] Jyvaskyla Cent Hosp, Dept Med, Jyvaskyla, Finland
[5] Univ Eastern Finland, Fac Hlth Sci, Kuopio, Finland
[6] Univ Helsinki, Dept Med, Cent Hosp, Helsinki, Finland
[7] Turku Univ Hosp, Dept Med, Turku, Finland
[8] Tampere City Hosp, Dept Med, Tampere, Finland
[9] Lapland Cent Hosp, Dept Med, Rovaniemi, Finland
[10] Seinajoki Cent Hosp, Dept Med, Seinajoki, Finland
[11] Rauma Cent Hosp, Dept Med, Rauma, Finland
[12] Kuopio Univ Hosp, Dept Med, Kuopio, Finland
[13] Univ Helsinki, Fac Med, Helsinki, Finland
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2017年 / 46卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [1] Obesity potentially protects against systemic bone loss in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors
    Lee, S. Y.
    Jung, K-H
    Park, S-G
    Kwon, S-R
    Park, W.
    Lim, M. J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 125 - 131
  • [2] Risk of Malignancy in Australian Rheumatoid Arthritis Patients Treated with Tumour Necrosis Factor Inhibitors.
    Van Doornum, Sharon
    Staples, Margaret P.
    March, Lynette
    Lassere, Marissa N.
    Buchbinder, Rachelle
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S154 - S154
  • [3] Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis
    Roberts, L
    McColl, GJ
    [J]. INTERNAL MEDICINE JOURNAL, 2004, 34 (12) : 687 - 693
  • [4] Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
    Mewar, Devesh
    Wilson, Anthony G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2011, 162 (04) : 785 - 791
  • [5] THE INFLUENCE OF TUMOUR NECROSIS FACTOR INHIBITORS ON DEMENTIA INCIDENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Vieira, Romana C. C.
    Watson, Kath
    Holmes, Clive
    McGuinness, Bernadette
    Hyrich, Kymme
    [J]. RHEUMATOLOGY, 2016, 55 : 73 - 74
  • [6] Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland
    Aaltonen, K. J.
    Joensuu, J. T.
    Pirila, L.
    Kauppi, M.
    Uutela, T.
    Varjolahti-Lehtinen, T.
    Yli-Kerttula, T.
    Isomaki, P.
    Nordstrom, D.
    Sokka, T.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 359 - 363
  • [7] Effectiveness and safety of the treatment with tumour necrosis factor a antagonists in rheumatoid arthritis patients
    Mendoza, MA
    Aznárez, HN
    Hernández, MJR
    Ruiz, FJM
    [J]. MEDICINA CLINICA, 2005, 125 (01): : 35 - 36
  • [8] PREDICTING DRUG IMMUNOGENICITY TO TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Alshehri, Mohammed
    Nair, Nisha
    Yap, Chuan Fu
    Isaacs, John D.
    Hyrich, Kimme
    Morgan, Ann W.
    Wilson, Anthony G.
    Barton, Anne
    Plant, Darren
    [J]. RHEUMATOLOGY, 2022, 61 : I13 - I13
  • [9] TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN RHEUMATOID ARTHRITIS THERAPY
    Laczna, Malgorzata
    Tarnowski, Maciej
    Kopytko, Patrycja
    Bujak, Joanna
    Pawlik, Andrzej
    [J]. POSTEPY BIOLOGII KOMORKI, 2020, 47 (03) : 247 - 263
  • [10] Correlation of patient preferences to treatment outcomes in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors in Greece
    Prodromos Sidiropoulos
    Andreas Bounas
    Panagiotis Athanassiou
    Christos Koutsianas
    Evangelia Petrikkou
    Evripidis Kaltsonoudis
    Alexandros Drosos
    Dimitrios Vassilopoulos
    [J]. Clinical Rheumatology, 2020, 39 : 3643 - 3652
12345